• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Poor Serologic Response to 2 Doses of an mRNA-based SARS-CoV-2 Vaccine in Lung Transplant Recipients.

作者信息

Hoffman Thijs W, Meek B, Rijkers G T, van Kessel D A

机构信息

Department of Pulmonology, St. Antonius Hospital, Nieuwegein, Utrecht, The Netherlands.

Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, Utrecht, The Netherlands.

出版信息

Transplantation. 2022 Jan 1;106(1):e103-e104. doi: 10.1097/TP.0000000000003966.

DOI:10.1097/TP.0000000000003966
PMID:34699459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8667675/
Abstract
摘要

相似文献

1
Poor Serologic Response to 2 Doses of an mRNA-based SARS-CoV-2 Vaccine in Lung Transplant Recipients.肺移植受者对两剂基于mRNA的SARS-CoV-2疫苗的血清学反应不佳。
Transplantation. 2022 Jan 1;106(1):e103-e104. doi: 10.1097/TP.0000000000003966.
2
Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.肺移植受者对第三剂基于mRNA的SARS-CoV-2疫苗的血清学反应。
Transpl Immunol. 2022 Jun;72:101599. doi: 10.1016/j.trim.2022.101599. Epub 2022 Apr 4.
3
Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients.mRNA SARS-CoV-2 疫苗在肺移植受者中的疗效和安全性。
J Infect Chemother. 2022 Aug;28(8):1153-1158. doi: 10.1016/j.jiac.2022.04.019. Epub 2022 May 17.
4
Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19.有新冠病毒疾病既往史的肾移植受者在接种第一剂基于信使核糖核酸的新冠病毒疫苗后产生强烈抗体反应。
Am J Transplant. 2021 Nov;21(11):3808-3810. doi: 10.1111/ajt.16764. Epub 2021 Jul 23.
5
COVID-19 After Vaccination in Lung Transplant Recipients: Real-Life Data.肺移植受者接种疫苗后感染新冠病毒：真实数据
Exp Clin Transplant. 2023 Mar;21(3):265-271. doi: 10.6002/ect.2022.0088. Epub 2022 Jul 22.
6
Antibody and T-cell response to a third dose of SARS-CoV-2 mRNA BNT162b2 vaccine in kidney transplant recipients.肾移植受者对第三剂SARS-CoV-2 mRNA BNT162b2疫苗的抗体和T细胞反应。
Kidney Int. 2021 Dec;100(6):1337-1340. doi: 10.1016/j.kint.2021.09.014. Epub 2021 Oct 4.
7
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).肾移植受者对 BNT162b2（辉瑞-生物科技）接种 SARS-CoV-2 疫苗的体液免疫反应受损。
Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756.
8
Efficacy and safety of the SARS-CoV-2 mRNA vaccine in lung transplant recipients: a possible trigger of rejection.新型冠状病毒疫苗在肺移植受者中的疗效和安全性：排斥反应的一个潜在触发因素。
Gen Thorac Cardiovasc Surg. 2023 Apr;71(4):251-257. doi: 10.1007/s11748-022-01887-3. Epub 2022 Oct 26.
9
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: Not alarming, but should be taken gravely.未接触过病毒的肾移植受者对SARS-CoV-2 mRNA疫苗BNT162b2的体液反应降低：虽不令人恐慌，但应予以高度重视。
Am J Transplant. 2021 Aug;21(8):2909. doi: 10.1111/ajt.16710. Epub 2021 Jun 18.
10
Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan.日本肺移植受者接种第三剂 SARS-CoV-2 mRNA 疫苗后的细胞和体液免疫应答。
Vaccine. 2023 Jul 12;41(31):4534-4540. doi: 10.1016/j.vaccine.2023.06.011. Epub 2023 Jun 9.

引用本文的文献

1
The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review.新冠疫苗对囊性纤维化患者的疗效：一项系统评价。
BMC Infect Dis. 2025 Mar 13;25(1):358. doi: 10.1186/s12879-025-10736-6.
2
Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis.COVID-19 疫苗在实体器官移植受者中的免疫原性：系统评价和荟萃分析。
Clin Microbiol Infect. 2023 Apr;29(4):441-456. doi: 10.1016/j.cmi.2022.12.004. Epub 2022 Dec 9.
3
Third dose of the BNT162b2 vaccine in cardiothoracic transplant recipients: predictive factors for humoral response.BNT162b2 疫苗在心胸器官移植受者中的第三剂接种：体液免疫应答的预测因素。
Clin Res Cardiol. 2023 Nov;112(11):1506-1516. doi: 10.1007/s00392-022-02075-2. Epub 2022 Aug 22.
4
Torque teno virus DNA load as a predictive marker of antibody response to a three-dose regimen of COVID-19 mRNA-based vaccine in lung transplant recipients.Torque teno 病毒 DNA 载量作为预测肺移植受者对三剂 COVID-19 mRNA 疫苗基于抗体反应的标志物。
J Heart Lung Transplant. 2022 Oct;41(10):1429-1439. doi: 10.1016/j.healun.2022.07.008. Epub 2022 Jul 16.
5
Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis.COVID-19 疫苗在实体器官移植受者中的体液和细胞免疫反应：系统评价和荟萃分析。
Transpl Infect Dis. 2022 Dec;24(6):e13926. doi: 10.1111/tid.13926. Epub 2022 Aug 12.
6
Immunogenicity and Risk Factors Associated With Poor Humoral Immune Response of SARS-CoV-2 Vaccines in Recipients of Solid Organ Transplant: A Systematic Review and Meta-Analysis.实体器官移植受者中 SARS-CoV-2 疫苗的体液免疫应答不良的免疫原性和相关危险因素：系统评价和荟萃分析。
JAMA Netw Open. 2022 Apr 1;5(4):e226822. doi: 10.1001/jamanetworkopen.2022.6822.
7
Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.肺移植受者对第三剂基于mRNA的SARS-CoV-2疫苗的血清学反应。
Transpl Immunol. 2022 Jun;72:101599. doi: 10.1016/j.trim.2022.101599. Epub 2022 Apr 4.